Nvidia Stock Was Supposed to Get a Lift From GTC This Week. It Dropped Instead.
The GTC conference did not provide many meaningful catalysts for the stock. Many of the announcements had been largely ...
Valmont Industries downgraded at Blair on earnings risk from tariffs
Valmont Industries (NYSE:VMI) -12% in Friday's trading to a five-month low after William Blair downgrades the infrastructure company to Market Perform from Outperform, citing potential for significant ...
Fierce Pharma10h
Novartis snags FDA nod for Fabhalta in another kidney disease but leaves room for rival Apellis
Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...
Beacon Roofing Supply (BECN) Receives a Rating Update from a Top Analyst
Truist Financial analyst Keith Hughes maintained a Hold rating on Beacon Roofing Supply (BECN – Research Report) today. The company’s shares ...
American Banker14h
How Walmart became a battleground for BNPL industry
As Klarna wins installment lending for the retail giant's OnePay app, rival Affirm seeks to downplay the loss.
Q1 Earnings Estimate for Genmab A/S Issued By William Blair
Equities researchers at William Blair issued their Q1 2026 earnings per share (EPS) estimates for Genmab A/S in a research note issued on Tuesday, March 18th. William Blair analyst M. Phipps ...
Equities Analysts Set Expectations for FibroGen Q1 Earnings
Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of FibroGen in a research report issued to clients and investors on Tuesday, March 18th.